ArticleInternational journal of retina and vitreous2026
One-year results of the intravitreal administration of faricimab in patients with naïve type 3 macular neovascularization.
Masaaki Saito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.